Bpd ates Cardiovascular risk factors and cardiovascular disease in patients with type 1 diabetes and end-stage renal disease candidates for kidney-pancreas transplantation: Trends from 1999 to 2017

被引:11
作者
Ruiz, Sabina [1 ]
Jesus Amor, Antonio [2 ,3 ]
Pane, Adriana [1 ]
Molina-Andujar, Alicia [4 ]
Montagud-Marrahi, Enrique [4 ]
Ventura-Aguiar, Pedro [4 ,5 ]
Ferrer-Fabrega, Joana [6 ]
Esmatjes, Enric [7 ,8 ]
机构
[1] Hosp Clin Barcelona, Endocrinol & Nutr Dept, Barcelona, Spain
[2] Hosp Clin Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Endocrinol & Nutr Dept, Madrid, Spain
[3] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain
[4] Hosp Clin Barcelona, Nephrol & Kidney Transplantat Dept, Renal Transplant Unit, Barcelona, Spain
[5] IDIBAPS, Fundacio Clin, CRB CELLEX, Lab Expt Nefrol & Transplantament LENIT, Barcelona, Spain
[6] Hosp Clin Barcelona, Dept Surg, HepatoBilioPancreat Surg & Liver & Pancreat Trans, Barcelona, Spain
[7] Hosp Clin Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Endocrinol & Nutr Dept, Diabet Unit, Barcelona, Spain
[8] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain
关键词
Type; 1; diabetes; End-stage renal disease; Kidney-pancreas transplantation; Cardiovascular risk factors; Cardiovascular disease; GLYCEMIC CONTROL; LDL CHOLESTEROL; MORTALITY; PREVALENCE; MELLITUS; COMPLICATIONS; SURVIVAL; SMOKING; IMPACT; HEART;
D O I
10.1016/j.diabres.2020.108135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To evaluate the changes in cardiovascular risk factors (CVRFs) and cardiovascular disease (CVD) in patients with type 1 diabetes (T1D) and end-stage renal disease (ESRD) who were candidates for kidney-pancreas transplantation (KPTx) from 1999 to 2017. Methods: Patients with T1D referred for KPTx evaluation were included. The cohort was divided into five groups according to the year of evaluation (1999-2002, 2003-2006, 2007-2010, 2011-2014 and 2015-2017). The control of CVRFs and the prevalence of prior CVD were evaluated. Results: We evaluated 360 patients (64.4% men, age 38.9 +/- 7.1 years). LDL-cholesterol <100 mg/dl increased from 22.7% to 76.9% (1999-2002 vs. 2015-2017; p < 0.001), as did the use of statins (from 24.7% to 74.5%; p < 0.001). Systolic blood pressure decreased from 138.8 +/- 27.6 to 125.1 +/- 27.9 mmHg (p = 0.001) and current smokers from 48% to 25% (p = 0.018). Intensive insulin treatment increased from 34.4% to 93.6% (p < 0.001). Diabetes duration before the initiation of renal replacement therapy increased from 23 +/- 5.5 to 26.9 +/- 8.9 years (p = 0.001). Overall, 30.3% had previous CVD, without significant changes over time (p = 0.699), albeit patients were older and had longer diabetes duration. Conclusions: Patients with T1D and ESRD referred for KPTx have better control of CVRFs over time, which might lead to a decrease in cardiovascular events. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:9
相关论文
共 38 条
[1]   2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) [J].
Aboyans, Victor ;
Ricco, Jean-Baptiste ;
Bartelink, Marie-Louise E. L. ;
Bjorck, Martin ;
Brodmann, Marianne ;
Cohnert, Tina ;
Collet, Jean-Philippe ;
Czerny, Martin ;
De Carlo, Marco ;
Debus, Sebastian ;
Espinola-Klein, Christine ;
Kahan, Thomas ;
Kownator, Serge ;
Mazzolai, Lucia ;
Naylor, A. Ross ;
Roffi, Marco ;
Roether, Joachim ;
Sprynger, Muriel ;
Tendera, Michal ;
Tepe, Gunnar ;
Venermo, Maarit ;
Vlachopoulos, Charalambos ;
Desormais, Ileana .
EUROPEAN HEART JOURNAL, 2018, 39 (09) :763-+
[2]   Smoking Is a Risk Factor for Graft Failure and Mortality after Renal Transplantation [J].
Agarwal, Pramod K. ;
Hellemons, Merel E. ;
Zelle, Dorien M. ;
van Ree, Rutger M. ;
van den Born, Jacob ;
van der Heide, Jaap J. Homan ;
Gans, Rijk O. B. ;
van Son, Willem J. ;
Navis, Gerjan ;
Bakker, Stephan J. L. .
AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (01) :26-31
[3]   Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit [J].
Amor, Antonio J. ;
Ortega, Emilio ;
Gimenez, Marga ;
Cofan, Montserrat ;
Blanco, Jesus ;
Pane, Adriana ;
Boswell, Laura ;
Vinagre, Irene ;
Esmatjes, Enric ;
Conget, Ignacio .
ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (08) :512-519
[4]  
Amor AJ, 2011, AV DIABETOL, V27, P137
[5]  
ANDREU J, 1984, NEFROLOGIA, V4, P147
[6]  
[Anonymous], COORDINACION TRANSPL
[7]  
[Anonymous], EUR HEART J
[8]  
[Anonymous], 2012, KIDNEY INT SUPPL
[9]   The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].
Baigent, Colin ;
Landray, Martin J. ;
Reith, Christina ;
Emberson, Jonathan ;
Wheeler, David C. ;
Tomson, Charles ;
Wanner, Christoph ;
Krane, Vera ;
Cass, Alan ;
Craig, Jonathan ;
Neal, Bruce ;
Jiang, Lixin ;
Hooi, Lai Seong ;
Levin, Adeera ;
Agodoa, Lawrence ;
Gaziano, Mike ;
Kasiske, Bertram ;
Walker, Robert ;
Massy, Ziad A. ;
Feldt-Rasmussen, Bo ;
Krairittichai, Udom ;
Ophascharoensuk, Vuddidhej ;
Fellstrom, Bengt ;
Holdaas, Hallvard ;
Tesar, Vladimir ;
Wiecek, Andrzej ;
Grobbee, Diederick ;
de Zeeuw, Dick ;
Gronhagen-Riska, Carola ;
Dasgupta, Tanaji ;
Lewis, David ;
Herrington, William ;
Mafham, Marion ;
Majoni, William ;
Wallendszus, Karl ;
Grimm, Richard ;
Pedersen, Terje ;
Tobert, Jonathan ;
Armitage, Jane ;
Baxter, Alex ;
Bray, Christopher ;
Chen, Yiping ;
Chen, Zhengming ;
Hill, Michael ;
Knott, Carol ;
Parish, Sarah ;
Simpson, David ;
Sleight, Peter ;
Young, Alan ;
Collins, Rory .
LANCET, 2011, 377 (9784) :2181-2192
[10]   Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019 [J].
Cefalu, William T. ;
Berg, Erika Gebel ;
Saraco, Mindy ;
Petersen, Matthew P. ;
Uelmen, Sacha ;
Robinson, Shamera .
DIABETES CARE, 2019, 42 :S124-S138